Teva Pharmaceutical Industries (TEVA) EPS (Diluted) Growth (3y) (2019 - 2026)
Teva Pharmaceutical Industries (TEVA) EPS (Diluted) Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 50.12% |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 6.26% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -70.43% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 6.24% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -6.96% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 64.19% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -18.62% |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 31.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 50.12% |
| Dec 31, 2025 | 32.69% |
| Sep 30, 2025 | 86.52% |
| Jun 30, 2025 | 43.68% |
| Mar 31, 2025 | 30.37% |
| Dec 31, 2024 | -21.25% |
| Sep 30, 2024 | -48.23% |
| Jun 30, 2024 | -82.55% |
| Mar 31, 2024 | 84.09% |
| Dec 31, 2023 | -139.38% |
| Sep 30, 2023 | 26.35% |
| Jun 30, 2023 | -102.98% |
| Mar 31, 2023 | -77.63% |
| Dec 31, 2022 | -140.55% |
| Sep 30, 2022 | 30.04% |
| Jun 30, 2022 | 26.51% |
| Mar 31, 2022 | -108.96% |
| Dec 31, 2021 | 99.64% |
| Sep 30, 2021 | 44.69% |
| Jun 30, 2021 | 40.94% |